#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5164252	B	Inhibition of NLRP3 inflammasome oligomerization in LPS-primed mouse BMDM cells assessed as prevention of ASC specks formation at 1 uM pretreated for 15 mins followed by MSU stimulation for 30 mins by DAPI staining based confocal microscopic analysis	Mus musculus	1	ALA5154853	cell-based format	Scientific Literature
2.	ALA5164253	B	Inhibition of NLRP3 inflammasome activation in LPS-primed mouse BMDM cells assessed as reduction in IL-1beta level at 1 uM pre-treated for 15 mins followed by ATP stimulation for 30 mins by ELISA relative to control	Mus musculus	15	ALA5154853	cell-based format	Scientific Literature
3.	ALA5164254	B	Inhibition of NLRP3 inflammasome activation in LPS-primed mouse BMDM cells assessed as reduction in IL-1beta level at 3 uM pre-treated for 15 mins followed by ATP stimulation for 30 mins by ELISA relative to control	Mus musculus	15	ALA5154853	cell-based format	Scientific Literature
4.	ALA5164255	B	Inhibition of NLRP3 inflammasome activation in LPS-primed mouse BMDM cells assessed as reduction in IL-1beta level at 10 uM pre-treated for 15 mins followed by ATP stimulation for 30 mins by ELISA relative to control	Mus musculus	15	ALA5154853	cell-based format	Scientific Literature
5.	ALA5164256	T	Cytotoxicity against mouse AML12 cells assessed as reduction in cell viability at 0.01 to 30 uM measured after 24 hrs by MTT assay	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
6.	ALA5164257	T	Cytotoxicity against mouse J774.A1 cells assessed as reduction in cell viability at 10 uM measured after 24 hrs by MTT assay relative to control	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
7.	ALA5164258	T	Cytotoxicity against mouse J774.A1 cells assessed as reduction in cell viability at 30 uM measured after 24 hrs by MTT assay relative to control	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
8.	ALA5164259	T	Cytotoxicity against mouse J774.A1 cells assessed as reduction in cell viability at 0.01 to 3 uM measured after 24 hrs by MTT assay	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
9.	ALA5164260	B	Inhibition of NLRP3 inflammasome activation in LPS-primed mouse BMDM cells assessed as reduction in ATP induced IL-1beta release pretreated for 15 mins followed by ATP stimulation for 30 mins by ELISA	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
10.	ALA5164261	B	Inhibition of NLRP3 inflammasome activation in LPS-primed mouse BMDM cells assessed as reduction in MSU induced IL-1beta release at 1 uM pretreated for 15 mins followed by MSU addition for 30 mins by ELISA	Mus musculus	2	ALA5154853	cell-based format	Scientific Literature
11.	ALA5164262	B	Inhibition of NLRP3 inflammasome oligomerization in LPS-primed mouse BMDM cells assessed as prevention of ASC specks formation at 1 uM pretreated for 15 mins followed by ATP stimulation for 30 mins by DAPI staining based confocal microscopic analysis	Mus musculus	1	ALA5154853	cell-based format	Scientific Literature
12.	ALA5164263	F	Inhibition of ATP-induced TNF-alpha production in LPS-primed mouse BMDM cells at 1 uM pretreated for 15 mins followed by ATP stimulation for 30 mins	Mus musculus	1	ALA5154853	cell-based format	Scientific Literature
13.	ALA5164264	B	Inhibition of AIM2 inflammasome activation in LPS-treated mouse BMDM assessed as reduction in poly-(dA:dT) induced IL-1beta release at 1 uM pretreated for 15 mins followed by poly-(dA:dT) addition and further incubated for 16 hrs by ELISA	Mus musculus	1	ALA5154853	cell-based format	Scientific Literature
14.	ALA5164265	B	Inhibition of NLRC4 inflammasome activation in LPS-treated mouse BMDM assessed as reduction in flagellin induced IL-1beta release at 1 uM pretreated for 15 mins followed by flagellin addition and further incubated for 16 hrs by ELISA	Mus musculus	1	ALA5154853	cell-based format	Scientific Literature
15.	ALA5164266	F	Antiinflammatory activity in MSU-induced acute gout arthritis in wild type male C57BL/6J mouse model assessed as decrease in paw inflammation at 3 to 10 mg/kg, ip measured after 24 hrs	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature
16.	ALA5164268	F	Antiinflammatory activity in MSU-induced acute gout arthritis in wild type male C57BL/6J mouse model assessed as decrease in paw inflammation at 3 mg/kg, ip measured after 24 hrs relative to control	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature
17.	ALA5164269	F	Antiinflammatory activity in MSU-induced acute gout arthritis in wild type female C57BL/6J mouse model assessed as decrease in paw inflammation at 3 mg/kg, ip measured after 24 hrs relative to control	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature
18.	ALA5164270	F	Antiinflammatory activity in MSU-induced acute gout arthritis in wild type male C57BL/6J mouse model assessed as decrease in paw inflammation at 10 mg/kg, ip measured after 24 hrs relative to control	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature
19.	ALA5164271	F	Antiinflammatory activity in MSU-induced acute gout arthritis in wild type female C57BL/6J mouse model assessed as decrease in paw inflammation at 10 mg/kg, ip measured after 24 hrs relative to control	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature
20.	ALA5164273	F	Antiinflammatory activity in MSU-induced acute gout arthritis in NLRP3 knockout male C57BL/6J mouse model assessed as reduction in paw inflammation at 3 to 10 mg/kg, ip measured after 24 hrs relative to control	Mus musculus	1	ALA5154853	organism-based format	Scientific Literature